The Role of PI3K in Met Driven Cancer: A Recap

The Receptor Tyrosine Kinase (RTK) Met, overexpressed or mutated in cancer, plays a major role in cancer progression and represents an attractive target for cancer therapy. However RTK inhibitors can lead to drug resistance, explaining the necessity to develop therapies that target downstream signal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hervieu, Alexia, Kermorgant, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207648/
https://www.ncbi.nlm.nih.gov/pubmed/30406111
http://dx.doi.org/10.3389/fmolb.2018.00086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207648/
https://www.ncbi.nlm.nih.gov/pubmed/30406111
http://dx.doi.org/10.3389/fmolb.2018.00086

Ejemplares similares